Translational Medicine

Translational Medicine is a specialized biotechnology and clinical research entity, primarily operating as a key subsidiary of Galapagos NV. The company focuses on bridging the gap between early-stage laboratory discoveries and clinical application, utilizing advanced biomarker strategies and proprietary target discovery platforms. Its core business involves the development of novel therapeutics across diverse modalities, including small molecules and CAR-T cell therapies, with a strong emphasis on inflammatory diseases, fibrosis, and oncology. By integrating human translational data and multi-omics profiling, the company aims to accelerate the delivery of transformational medicines to patients with high unmet medical needs.